Livelsberger Financial Advisory Invests $38,000 in CVS Health Co. (NYSE:CVS)

Livelsberger Financial Advisory purchased a new position in CVS Health Co. (NYSE:CVS) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 480 shares of the pharmacy operator’s stock, valued at approximately $38,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Atticus Wealth Management LLC lifted its position in shares of CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares during the period. USA Financial Formulas lifted its position in shares of CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. acquired a new position in shares of CVS Health during the 4th quarter valued at $32,000. Creekmur Asset Management LLC acquired a new position in shares of CVS Health during the 4th quarter valued at $34,000. Finally, Scarborough Advisors LLC acquired a new position in shares of CVS Health during the 4th quarter valued at $37,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Up 1.5 %

Shares of CVS Health stock opened at $61.10 on Tuesday. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a market cap of $76.70 billion, a price-to-earnings ratio of 10.74, a PEG ratio of 0.57 and a beta of 0.53. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The company’s 50-day moving average price is $61.24 and its 200-day moving average price is $70.90.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). The company had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the company posted $2.20 earnings per share. On average, equities analysts expect that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.35%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s payout ratio is 46.75%.

Analyst Ratings Changes

A number of research analysts recently issued reports on CVS shares. Mizuho dropped their target price on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. UBS Group lowered shares of CVS Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $85.00 to $60.00 in a research note on Thursday, May 2nd. Barclays decreased their price target on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday, May 2nd. Bank of America decreased their price target on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Finally, Argus decreased their price target on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, May 8th. Eleven analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $75.05.

Insider Buying and Selling

In other CVS Health news, Director Edward J. Ludwig purchased 1,000 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was bought at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now directly owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.24% of the stock is currently owned by insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.